Volume 29, Number 11—November 2023
Research
Risk Factors for Recent HIV Infections among Adults in 14 Countries in Africa Identified by Population-Based HIV Impact Assessment Surveys, 2015–2019
Table 5
Category |
Crude odds ratio (95% CI) |
Adjusted odds ratio (95% CI) |
---|---|---|
Region | ||
Eastern Africa | 0.82 (0.53–1.28) | 1.10 (0.68–1.76) |
Southeastern Africa | 0.57 (0.37–0.88) | 1.03 (0.61–1.73) |
Southern Africa | 0.57 (0.37–0.89) | 1.18 (0.66–2.11) |
Western Africa |
Referent |
Referent |
Sex | ||
F | 0.96 (0.67–1.38) | 1.00 (0.61–1.65) |
M |
Referent |
Referent |
Age Group, y | ||
15–24 | 6.03 (3.81–9.53) | 4.79 (2.79–8.24) |
25–34 | 2.60 (1.69–4.01) | 2.23 (1.43–3.47) |
35–49 |
Referent |
Referent |
Marital Status | ||
Married/cohabiting | 0.45 (0.30–0.68) | 0.86 (0.49–1.49) |
Divorced/separated/widowed | 0.61 (0.35–1.05) | 1.09 (0.58–2.06) |
Never married |
Referent |
Referent |
Age of Sexual Debut, y | ||
<18 | 1.49 (1.05–2.11) | 1.19 (0.82–1.71) |
>18 |
Referent |
Referent |
No. sexual partners in previous 12 mo | ||
1 | Referent | Referent |
>2 |
1.96 (1.35–2.85) |
1.83 (1.17–2.86) |
Condom used at last sex | ||
Condom used | 0.51 (0.34–0.77) | 0.46 (0.28–0.74) |
Condom not used |
Referent |
Referent |
HIV status of sexual partners | ||
>1 partner thought/told/tested HIV+ | 0.22 (0.10–0.49) | 0.17 (0.08–0.36) |
>1 partner with unknown HIV status | 1.35 (0.95–1.92) | 1.18 (0.80–1.76) |
All partners thought/told/tested HIV– |
Referent |
Referent |
Age difference with sexual partners | ||
Partners <5 years older than participant | Referent | Referent |
>1 partner 5–9 years older than participant | 1.09 (0.74–1.59) | 1.08 (0.68–1.72) |
>1 partner >10 years older than participant |
0.82 (0.54–1.24) |
0.84 (0.50–1.42) |
Community-level viremia* | ||
Lowest quartile | Referent | Referent |
Second quartile | 0.90 (0.40–2.01) | 1.01 (0.43–2.39) |
Third quartile | 0.72 (0.34–1.54) | 0.86 (0.37–1.99) |
Highest quartile | 0.58 (0.28–1.19) | 0.70 (0.31–1.62) |
*Lowest quartile (0–25%), <39.38 viremic persons/10,000 population; second quartile (25%–50%), 39.38–122.51 viremic persons/10,000 population; third quartile (50%–75%), 122.52–297.03 viremic persons/10,000 population; highest quartile (76%–100%), >297.03 viremic persons/10,000 population.
Page created: October 02, 2023
Page updated: October 23, 2023
Page reviewed: October 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.